Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY
Portfolio Pulse from Benzinga Newsdesk
Finch Therapeutics Gr (NASDAQ:FNCH) reported Q3 losses of $(1.51) per share, a 94.05% increase over losses of $(25.38) per share from the same period last year.
November 08, 2023 | 11:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Finch Therapeutics Gr reported a significant improvement in its Q3 losses compared to the same period last year.
Finch Therapeutics Gr reported a significant improvement in its Q3 losses compared to the same period last year. This indicates a positive financial performance and could potentially lead to a positive reaction in the market, hence the score of 1.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100